Ледин Евгений Витальевич
24 works · 595 citations · h-index 5
Top works
- Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
- Практические рекомендации по лекарственному лечению билиарного рака
- Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
- Практические рекомендации по лекарственному лечению больных гепатоцеллюлярным раком
- Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
- The role of surgery (metastasectomy) in advanced BRAF positive melanoma during modern therapy.
- Coping Behavior cancer patients with different levels of uncertainty in illness
- Phase Ib study of BI 836880 (VEGF/Ang2 inhibitor) plus ezabenlimab (BI 754091; anti-PD-1 antibody) in patients (pts) with advanced hepatocellular carcinoma (HCC).
- 532P Phase Ib study evaluating BI 836880 (VEGF/Ang2 nanobody) in combination with ezabenlimab (BI 754091; anti-PD-1 antibody) in patients with solid tumours
- The clinical effectiveness and safety of re-induction oxaliplatin, irinotecan and fluorouracil (FOLFOXIRI regimen) for the treatment of metastatic colorectal cancer after two lines of chemotherapy (oxaliplatin- and irinotecan-based regimens)
- Применение панелей комплексного молекулярного профилирования при опухолях желудочно-кишечного тракта. Обзор литературы и собственные результаты
- CIMICIFUGA RACEMOSA EXTRACT AS AN ALTERNATIVE TO HORMONE THERAPY IN THE MANAGEMENT OF ESTROGEN DEFICIENCIES
- Clinical application of next-generation sequencing in cancer patients.
- Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation
- Multicenter observational prospective study of nivolumab (Nivo) as 2+ line treatment in advanced refractory NSCLC pts: Clinical and quality of life outcomes.
- Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
- Utility of public Knowledge Bases (KB) for comprehensive tumor molecular profiling (CTMP) result interpretation.
- Effectiveness and tolerability of FOLFOXIRI regimen in the third- and subsequent lines of therapy in patients with metastatic colorectal cancer.
- Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results
- 515P Comprehensive molecular profiling in gastrointestinal tumors